Google Custom Search
HIV-HBV Coinfection Top News Articles
   
HIV/HBV and HIV/HCV Coinfected People with Impaired Liver Function and Inflammation Have Higher Risk of Non-AIDS Death
3-9-2010
Poor Response to Hepatitis B Vaccine Predicts HIV Disease Progression
3-9-2010
HIV/HBV and HIV/HCV Coinfected Patients in Africa Have Slower CD4 Recovery on Antiretroviral Therapy, but Not Increased Mortality
3-6-2010
Liver Toxicity in an International Cohort of HIV/HBV Coinfected Patients on Long-term Antiretroviral Therapy
3-2-2010
Epidemiology of HIV/HBV Coinfection in a U.S. Military Cohort
1-29-2010
HIV/HBV Coinfected Patients with Elevated ALT and AST Are at Greater Risk for Liver Disease Progression
1-19-2010
Tenofovir (Viread) Suppresses HBV Viral Load Long-term in HIV/HBV Coinfected Patients, but Kidney Function May Decline
11-3-2009
T-cell Response against Hepatitis B Virus Is Impaired in HIV-HBV Coinfected Individuals
9-25-2009
HIV-HBV Coinfected Patients Respond to Antiretroviral Therapy as well as HIV Monoinfected, but Have a Higher Risk of Non-AIDS Death
9-04-2009
HIV Coinfection Has Little Effect on Response to Chronic Hepatitis B Treatment
6-16-2009
Patients Coinfected with HIV and Hepatitis B Virus Can Undergo Liver Transplantation with Excellent Results
6-5-2009
Mechanisms of Accelerated Fibrosis in HIV-HCV and HIV-HBV Coinfected Individuals
5/15/09
Laboratory Study Shows Hepatitis B Drug Entecavir (Baraclude) -- But Not Telbivudine (Tyzeka) -- Has Activity against Multiple Strains of HIV
5/15/09
Combination Antiretroviral Therapy is Well-tolerated and Rapidly Suppresses HBV Viral Load in HIV-HBV Coinfected Patients
5/08/09
Occult Hepatitis B Virus in HIV Patients with Low CD4 Cell Counts May Resolve after Starting Antiretroviral Therapy
4/21/09
Liver Disease Is a Growing Cause of Death for HIV Positive People in France, but Has Leveled Off in Spain
4/07/09

ImQuest Identifies First Non-nucleoside Inhibitors of Hepatitis B Virus
4/07/09

Effect of HIV Immunosuppression on Response to Hepatitis B and HBV Evolution
4/03/09
Outcomes of Liver Transplantation in HIV Positive Recipients Coinfected with Hepatitis B or C
3/24/09
ALT Flares in HIV-HBV Coinfected Patients after Starting Antiretroviral Therapy
3/20/09
Studies Look at Liver Fibrosis in HIV-HCV and HIV-HBV Coinfected
People
3/13/09
Treatment of HIV-HBV Coinfected Patients in South Africa
1/10/09
SMART Study Shows Antiretroviral Treatment Interruption Is Particularly Risky for Patients with HIV-HBV or HIV-HCV Coinfection
12/05/08
Baseline CD4 Cell Count Predicts HBV DNA Decline in HIV Negative and HIV Positive Patients Treated with Adefovir (Hepsera)
12/05/08
Management of HIV Positive Patients with Chronic Hepatitis B Who Are Not Eligible for Antiretroviral Therapy
11/25/08
Tenofovir (Viread) for Patients with HIV-HBV Coinfection
11/21/2008
HAART Improves Hepatitis B Vaccine Response Regardless of CD4 Count
11/07/2008
Liver Enzyme Elevations in HIV Positive Individuals with Occult Hepatitis B Virus Infection
10/17/08
Thai Study Confirms Efficacy of Tenofovir (Viread) Regimens for HIV-HBV Coinfected Patients
10/14/08
Laboratory Study Provides Details on Entecavir (Baraclude) Activity against Various Types of HIV
8/29/08
HIV Positive Individuals Are at Higher Risk of Occult Hepatitis B Virus Infection, but Occult Hepatitis C Virus Is Rare
8/22/08
Predictors of Hepatitis B Surface Antigen Loss in HIV-HBV Coinfected Individuals
8/08/08
Updated Recommendations for Management of HIV Positive Patients with Chronic Hepatitis B Virus Coinfection
7/15/2008
Multicenter Evaluation Sheds Further Light on Anti-HIV Activity of Entecavir (Baraclude)
6/20/08
Influence of Occult Hepatitis B Virus on Liver Disease Progression and Response to Interferon-based Therapy in HIV-HCV Coinfected Patients
6/10/08
FDA Proposes New Rule to Provide Updated Information on Use of Prescription Drugs and Biological Products during Pregnancy and Breast-feeding
5/30/08
Risk of Using Entecavir (Baraclude) without Concomitant Antiretroviral Therapy in HIV-HBV Coinfected Patients
5/15/08
Hepatitis B Coinfection Does Not Interfere with Response to Antiretroviral Therapy
4/15/08
Another Report of Drug-resistant HIV in a Patient Treated with Entecavir (Baraclude) for Hepatitis B
4/11/08

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 



Updated Recommendations for Management of HIV Positive Patients with Chronic Hepatitis B Virus Coinfection
Reports on Most Recent
Hepatits-related
Research Conferences
FDA-approved Combination Therapies for Chronic HBV Infection
Baraclude  (entecavir)
Epivir-HBV
   (lamivudine; 3TC)
Intron A   (interferon alfa-2b)

Hepsera  
(adefovir dipivoxil)
Pegasys  
(peginterferon alfa-2a)
Tyzeka   
(telbivudine)
FDA-approved HIV
and AIDS Treatments
Protease Inhibitors PIs
non Nucleoside Reverse
  
Transcriptase Inhibitors nNRTIs
Nucleoside / Nucleotide Reverse
  
Transcriptase Inhibitors NRTIs

Fixed-dose Combinations

Entry / Fusion Inhibitors EIs
Integrase Inhibitors